Los Angeles Capital Management’s Revolution Medicines RVMD Stock Holding History

Los Angeles Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$164K	Buy	877 +130	+17%	+$19K	﹤0.01%	1217
2026 Q1	$72.6K	Hold	747	–	–	﹤0.01%	1416
2025 Q4	$44K	Buy	+747	New	+$49K	﹤0.01%	1644
2024 Q4	–	Sell	-7,228	Closed	-$328K	–	1228
2024 Q3	$328K	Sell	7,228 -223	-3%	-$9.71K	﹤0.01%	982
2024 Q2	$289K	Sell	7,451 -1,567	-17%	-$58.6K	﹤0.01%	1023
2024 Q1	$291K	Buy	9,018 +217	+2%	+$6.43K	﹤0.01%	1016
2023 Q4	$252K	Buy	+8,801	New	+$211K	﹤0.01%	1058
2023 Q3	–	Sell	-11,614	Closed	-$311K	–	1220
2023 Q2	$311K	Buy	+11,614	New	+$285K	﹤0.01%	987

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Los Angeles Capital Management's RVMD Position: Q2 2026 in Review

Los Angeles Capital Management increased its Revolution Medicines (RVMD) stake by 17% in Q2 2026, buying an estimated $19K and bringing the position to 877 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #1217.

Los Angeles Capital Management first reported a position in RVMD in Q2 2023 and has held it in 8 quarters since. The position peaked at $328K in Q3 2024. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Los Angeles Capital Management held 877 shares of Revolution Medicines worth $164K as of Q2 2026.
Los Angeles Capital Management bought 130 Revolution Medicines shares in Q2 2026, an estimated $19K.
Revolution Medicines made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1217 holding.
Los Angeles Capital Management first reported a position in Revolution Medicines in Q2 2023 and has held it in 8 quarters since.
Los Angeles Capital Management's Revolution Medicines position peaked at $328K in Q3 2024.
694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.